Cargando…

Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Detalles Bibliográficos
Autores principales: Askanase, Anca D., Zhao, Enxu, Zhu, Julie, Bilyk, Roman, Furie, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572253/
https://www.ncbi.nlm.nih.gov/pubmed/34460089
http://dx.doi.org/10.1007/s40744-021-00353-5
_version_ 1784595181941555200
author Askanase, Anca D.
Zhao, Enxu
Zhu, Julie
Bilyk, Roman
Furie, Richard A.
author_facet Askanase, Anca D.
Zhao, Enxu
Zhu, Julie
Bilyk, Roman
Furie, Richard A.
author_sort Askanase, Anca D.
collection PubMed
description
format Online
Article
Text
id pubmed-8572253
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-85722532021-11-15 Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Askanase, Anca D. Zhao, Enxu Zhu, Julie Bilyk, Roman Furie, Richard A. Rheumatol Ther Correction Springer Healthcare 2021-08-30 /pmc/articles/PMC8572253/ /pubmed/34460089 http://dx.doi.org/10.1007/s40744-021-00353-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Askanase, Anca D.
Zhao, Enxu
Zhu, Julie
Bilyk, Roman
Furie, Richard A.
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
title Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
title_full Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
title_fullStr Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
title_full_unstemmed Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
title_short Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
title_sort correction to: repository corticotropin injection for persistently active systemic lupus erythematosus: results from a phase 4, multicenter, randomized, double-blind, placebo-controlled trial
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572253/
https://www.ncbi.nlm.nih.gov/pubmed/34460089
http://dx.doi.org/10.1007/s40744-021-00353-5
work_keys_str_mv AT askanaseancad correctiontorepositorycorticotropininjectionforpersistentlyactivesystemiclupuserythematosusresultsfromaphase4multicenterrandomizeddoubleblindplacebocontrolledtrial
AT zhaoenxu correctiontorepositorycorticotropininjectionforpersistentlyactivesystemiclupuserythematosusresultsfromaphase4multicenterrandomizeddoubleblindplacebocontrolledtrial
AT zhujulie correctiontorepositorycorticotropininjectionforpersistentlyactivesystemiclupuserythematosusresultsfromaphase4multicenterrandomizeddoubleblindplacebocontrolledtrial
AT bilykroman correctiontorepositorycorticotropininjectionforpersistentlyactivesystemiclupuserythematosusresultsfromaphase4multicenterrandomizeddoubleblindplacebocontrolledtrial
AT furiericharda correctiontorepositorycorticotropininjectionforpersistentlyactivesystemiclupuserythematosusresultsfromaphase4multicenterrandomizeddoubleblindplacebocontrolledtrial